$IDXX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IDEXX LABORATORIES INC /DE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in IDEXX LABORATORIES INC /DE. Get notifications about new insider transactions in IDEXX LABORATORIES INC /DE for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 ... 28 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 02 2019 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Buy | M | 64.24 | 7,780 | 499,787 | 12,034 | 4.3 K to 12 K (+182.89 %) |
| Nov 14 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 254.23 | 20,353 | 5,174,258 | 926,964 | 947.3 K to 927 K (-2.15 %) |
| Nov 14 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 253.83 | 15,647 | 3,971,683 | 947,317 | 963 K to 947.3 K (-1.62 %) |
| Nov 12 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 264.49 | 3,018 | 798,219 | 962,964 | 966 K to 963 K (-0.31 %) |
| Nov 12 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 263.39 | 12,765 | 3,362,196 | 965,982 | 978.7 K to 966 K (-1.30 %) |
| Nov 12 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 262.72 | 22,007 | 5,781,666 | 978,747 | 1 M to 978.7 K (-2.20 %) |
| Nov 06 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Option Exercise | M | 45.84 | 53,820 | 2,467,109 | 0 | |
| Nov 06 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 266.54 | 11,794 | 3,143,539 | 1,000,754 | 1 M to 1 M (-1.16 %) |
| Nov 06 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 265.39 | 3,839 | 1,018,811 | 1,012,548 | 1 M to 1 M (-0.38 %) |
| Nov 06 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 277.87 | 1,300 | 361,233 | 1,016,387 | 1 M to 1 M (-0.13 %) |
| Nov 06 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 281.74 | 2,984 | 840,702 | 1,017,687 | 1 M to 1 M (-0.29 %) |
| Nov 06 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 280.08 | 3,402 | 952,834 | 1,020,671 | 1 M to 1 M (-0.33 %) |
| Nov 06 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 279.43 | 1,891 | 528,408 | 1,024,073 | 1 M to 1 M (-0.18 %) |
| Nov 06 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 280.47 | 4,247 | 1,191,137 | 1,025,964 | 1 M to 1 M (-0.41 %) |
| Nov 06 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 279.72 | 26,198 | 7,328,222 | 1,030,211 | 1.1 M to 1 M (-2.48 %) |
| Nov 06 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 278.90 | 23,375 | 6,519,257 | 1,056,409 | 1.1 M to 1.1 M (-2.16 %) |
| Nov 06 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Buy | M | 45.84 | 53,820 | 2,467,109 | 1,079,784 | 1 M to 1.1 M (+5.25 %) |
| Nov 05 2019 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Sell | S | 279.99 | 983 | 275,225 | 2,916 | 3.9 K to 2.9 K (-25.21 %) |
| Nov 05 2019 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Sell | S | 279.10 | 2,300 | 641,937 | 3,899 | 6.2 K to 3.9 K (-37.10 %) |
| Nov 05 2019 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Option Exercise | M | 306.53 | 27,992 | 8,580,276 | 27,992 | |
| Oct 31 2019 | IDXX | IDEXX LABORATORIES ... | Vandebroek Sophie V. | Director | Grant | A | 273.85 | 73 | 19,991 | 3,251 | 3.2 K to 3.3 K (+2.30 %) |
| Oct 31 2019 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Grant | A | 273.85 | 23 | 6,299 | 2,812 | 2.8 K to 2.8 K (+0.82 %) |
| Oct 31 2019 | IDXX | IDEXX LABORATORIES ... | ESSIG STUART | Director | Grant | A | 273.85 | 73 | 19,991 | 792 | 719 to 792 (+10.15 %) |
| Sep 04 2019 | IDXX | IDEXX LABORATORIES ... | SAMAD SAM | Director | Option Exercise | A | 289.74 | 1,025 | 296,984 | 1,025 | |
| Sep 04 2019 | IDXX | IDEXX LABORATORIES ... | SAMAD SAM | Director | Option Exercise | A | 0.00 | 293 | 0 | 293 | |
| Aug 20 2019 | IDXX | IDEXX LABORATORIES ... | HENDERSON REBECCA M | Director | Sell | S | 271.17 | 4,000 | 1,084,686 | 14,696 | 18.7 K to 14.7 K (-21.39 %) |
| Aug 14 2019 | IDXX | IDEXX LABORATORIES ... | Vandebroek Sophie V. | Director | Gift | G | 0.00 | 6,000 | 0 | 6,000 | 0 to 6 K |
| Aug 14 2019 | IDXX | IDEXX LABORATORIES ... | Vandebroek Sophie V. | Director | Gift | G | 0.00 | 6,000 | 0 | 3,178 | 9.2 K to 3.2 K (-65.37 %) |
| Aug 12 2019 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Sell | S | 274.44 | 2,300 | 631,212 | 10,315 | 12.6 K to 10.3 K (-18.23 %) |
| Aug 12 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman of the Boa ... | Option Exercise | M | 45.84 | 10,000 | 458,400 | 43,820 | |
| Aug 12 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman of the Boa ... | Sell | S | 273.35 | 1,522 | 416,038 | 1,025,942 | 1 M to 1 M (-0.15 %) |
| Aug 12 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman of the Boa ... | Sell | S | 272.64 | 8,478 | 2,311,448 | 1,027,464 | 1 M to 1 M (-0.82 %) |
| Aug 12 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman of the Boa ... | Buy | M | 45.84 | 10,000 | 458,400 | 1,035,942 | 1 M to 1 M (+0.97 %) |
| Aug 09 2019 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Interim President & ... | Option Exercise | M | 47.53 | 6,306 | 299,724 | 0 | |
| Aug 09 2019 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Interim President & ... | Option Exercise | M | 47.53 | 2,848 | 135,365 | 0 | |
| Aug 09 2019 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Interim President & ... | Option Exercise | M | 45.84 | 2,204 | 101,031 | 13,824 | |
| Aug 09 2019 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Interim President & ... | Buy | M | 47.53 | 6,306 | 299,724 | 34,628 | 28.3 K to 34.6 K (+22.27 %) |
| Aug 09 2019 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Interim President & ... | Buy | M | 47.53 | 2,848 | 135,365 | 28,322 | 25.5 K to 28.3 K (+11.18 %) |
| Aug 09 2019 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Interim President & ... | Buy | M | 45.84 | 2,204 | 101,031 | 25,474 | 23.3 K to 25.5 K (+9.47 %) |
| Aug 09 2019 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Gift | G | 0.00 | 2,500 | 0 | 6,199 | 8.7 K to 6.2 K (-28.74 %) |
| Aug 09 2019 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Gift | G | 0.00 | 5,283 | 0 | 8,699 | 3.4 K to 8.7 K (+154.65 %) |
| Aug 09 2019 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Gift | G | 0.00 | 5,283 | 0 | 6,717 | 12 K to 6.7 K (-44.02 %) |
| Aug 08 2019 | IDXX | IDEXX LABORATORIES ... | Kingsley Lawrence D | Director | Buy | P | 266.41 | 375 | 99,904 | 7,778 | 7.4 K to 7.8 K (+5.07 %) |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | Vandebroek Sophie V. | Director | Option Exercise | M | 63.95 | 6,056 | 387,281 | 1,666 | |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | Vandebroek Sophie V. | Director | Option Exercise | M | 64.69 | 2,988 | 193,294 | 0 | |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | Vandebroek Sophie V. | Director | Sell | S | 263.86 | 6,056 | 1,597,927 | 9,178 | 15.2 K to 9.2 K (-39.75 %) |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | Vandebroek Sophie V. | Director | Buy | M | 63.95 | 6,056 | 387,281 | 15,234 | 9.2 K to 15.2 K (+65.98 %) |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | Vandebroek Sophie V. | Director | Sell | S | 263.86 | 2,988 | 788,409 | 9,178 | 12.2 K to 9.2 K (-24.56 %) |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | Vandebroek Sophie V. | Director | Buy | M | 64.69 | 2,988 | 193,294 | 12,116 | 9.1 K to 12.1 K (+32.73 %) |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | A | 0.00 | 961 | 0 | 8,780 | |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | A | 260.07 | 10,058 | 2,615,784 | 0 | |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Interim President & ... | Option Exercise | M | 45.84 | 10,000 | 458,400 | 16,028 | |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Interim President & ... | Option Exercise | A | 0.00 | 1,923 | 0 | 9,439 | |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Interim President & ... | Option Exercise | A | 260.07 | 20,116 | 5,231,568 | 20,116 | |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Interim President & ... | Sell | S | 258.80 | 4,599 | 1,190,208 | 23,270 | 27.9 K to 23.3 K (-16.50 %) |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Interim President & ... | Sell | S | 258.07 | 5,401 | 1,393,836 | 27,869 | 33.3 K to 27.9 K (-16.23 %) |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JAY | Interim President & ... | Buy | M | 45.84 | 10,000 | 458,400 | 33,270 | 23.3 K to 33.3 K (+42.97 %) |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Option Exercise | M | 178.26 | 1,999 | 356,342 | 7,435 | |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Option Exercise | M | 141.60 | 4,438 | 628,421 | 5,948 | |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Option Exercise | M | 67.85 | 6,190 | 419,992 | 4,559 | |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Option Exercise | M | 67.85 | 3 | 204 | 2,069 | |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Option Exercise | M | 79.54 | 136 | 10,817 | 2,226 | |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Option Exercise | M | 79.54 | 638 | 50,747 | 748 | |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Option Exercise | M | 62.00 | 2,010 | 124,620 | 0 | |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Sell | S | 264.73 | 3,347 | 886,046 | 1,425 | 4.8 K to 1.4 K (-70.14 %) |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Sell | S | 264.25 | 2,547 | 673,055 | 4,772 | 7.3 K to 4.8 K (-34.80 %) |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Sell | S | 263.89 | 12,067 | 3,184,349 | 7,319 | 19.4 K to 7.3 K (-62.25 %) |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Buy | M | 178.26 | 1,999 | 356,342 | 19,386 | 17.4 K to 19.4 K (+11.50 %) |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Buy | M | 141.60 | 4,438 | 628,421 | 17,387 | 12.9 K to 17.4 K (+34.27 %) |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Buy | M | 67.85 | 6,190 | 419,992 | 12,949 | 6.8 K to 12.9 K (+91.58 %) |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Buy | M | 67.85 | 3 | 204 | 6,759 | 6.8 K to 6.8 K (+0.04 %) |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Buy | M | 79.54 | 136 | 10,817 | 6,756 | 6.6 K to 6.8 K (+2.05 %) |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Buy | M | 79.54 | 638 | 50,747 | 6,620 | 6 K to 6.6 K (+10.67 %) |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Buy | M | 62.00 | 2,010 | 124,620 | 5,982 | 4 K to 6 K (+50.60 %) |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman of the Boa ... | Option Exercise | M | 45.84 | 10,000 | 458,400 | 63,820 | |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman of the Boa ... | Option Exercise | M | 45.84 | 10,000 | 458,400 | 73,820 | |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman of the Boa ... | Sell | S | 264.38 | 10,000 | 2,643,798 | 1,025,942 | 1 M to 1 M (-0.97 %) |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman of the Boa ... | Buy | M | 45.84 | 10,000 | 458,400 | 1,035,942 | 1 M to 1 M (+0.97 %) |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman of the Boa ... | Sell | S | 261.67 | 2,000 | 523,338 | 1,025,942 | 1 M to 1 M (-0.19 %) |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman of the Boa ... | Sell | S | 260.39 | 4,200 | 1,093,630 | 1,027,942 | 1 M to 1 M (-0.41 %) |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman of the Boa ... | Sell | S | 259.54 | 2,400 | 622,886 | 1,032,142 | 1 M to 1 M (-0.23 %) |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman of the Boa ... | Sell | S | 258.61 | 1,000 | 258,613 | 1,034,542 | 1 M to 1 M (-0.10 %) |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman of the Boa ... | Sell | S | 257.19 | 400 | 102,874 | 1,035,542 | 1 M to 1 M (-0.04 %) |
| Aug 07 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman of the Boa ... | Buy | M | 45.84 | 10,000 | 458,400 | 1,035,942 | 1 M to 1 M (+0.97 %) |
| Aug 01 2019 | IDXX | IDEXX LABORATORIES ... | Vandebroek Sophie V. | Director | Grant | A | 286.05 | 70 | 20,024 | 9,178 | 9.1 K to 9.2 K (+0.77 %) |
| Aug 01 2019 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Grant | A | 286.05 | 22 | 6,293 | 2,789 | 2.8 K to 2.8 K (+0.80 %) |
| Aug 01 2019 | IDXX | IDEXX LABORATORIES ... | ESSIG STUART | Director | Grant | A | 286.05 | 70 | 20,024 | 719 | 649 to 719 (+10.79 %) |
| Jun 04 2019 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 466 | 0 | 3,012 | |
| Jun 04 2019 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Payment of Exercise | F | 249.77 | 118 | 29,473 | 4,212 | 4.3 K to 4.2 K (-2.73 %) |
| Jun 04 2019 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Buy | M | 0.00 | 466 | 0 | 4,330 | 3.9 K to 4.3 K (+12.06 %) |
| Jun 04 2019 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Sell | S | 250.14 | 2,600 | 650,363 | 12,595 | 15.2 K to 12.6 K (-17.11 %) |
| May 15 2019 | IDXX | IDEXX LABORATORIES ... | HENDERSON REBECCA M | Director | Option Exercise | M | 43.68 | 8,790 | 383,947 | 0 | |
| May 15 2019 | IDXX | IDEXX LABORATORIES ... | HENDERSON REBECCA M | Director | Sell | S | 241.57 | 8,790 | 2,123,422 | 18,696 | 27.5 K to 18.7 K (-31.98 %) |
| May 15 2019 | IDXX | IDEXX LABORATORIES ... | HENDERSON REBECCA M | Director | Buy | M | 43.68 | 8,790 | 383,947 | 27,486 | 18.7 K to 27.5 K (+47.02 %) |
| May 13 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Sell | S | 245.41 | 1,812 | 444,683 | 3,952 | 5.8 K to 4 K (-31.44 %) |
| May 10 2019 | IDXX | IDEXX LABORATORIES ... | Vandebroek Sophie V. | Director | Option Exercise | A | 245.79 | 1,404 | 345,089 | 1,404 | |
| May 10 2019 | IDXX | IDEXX LABORATORIES ... | Vandebroek Sophie V. | Director | Option Exercise | A | 0.00 | 427 | 0 | 3,371 | |
| May 10 2019 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Option Exercise | A | 245.79 | 1,404 | 345,089 | 1,404 | |
| May 10 2019 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Option Exercise | A | 0.00 | 427 | 0 | 4,145 | |
| May 10 2019 | IDXX | IDEXX LABORATORIES ... | Kingsley Lawrence D | Director | Option Exercise | A | 245.79 | 1,404 | 345,089 | 1,404 | |
| May 10 2019 | IDXX | IDEXX LABORATORIES ... | Kingsley Lawrence D | Director | Option Exercise | A | 0.00 | 427 | 0 | 1,147 | |
| May 10 2019 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Option Exercise | A | 245.79 | 1,404 | 345,089 | 1,404 | |
| May 10 2019 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Option Exercise | A | 0.00 | 427 | 0 | 2,793 | |
| May 10 2019 | IDXX | IDEXX LABORATORIES ... | HENDERSON REBECCA M | Director | Option Exercise | A | 245.79 | 1,404 | 345,089 | 1,404 | |
| May 10 2019 | IDXX | IDEXX LABORATORIES ... | HENDERSON REBECCA M | Director | Option Exercise | A | 0.00 | 427 | 0 | 17,745 | |
| May 10 2019 | IDXX | IDEXX LABORATORIES ... | ESSIG STUART | Director | Option Exercise | A | 245.79 | 1,404 | 345,089 | 1,404 | |
| May 10 2019 | IDXX | IDEXX LABORATORIES ... | ESSIG STUART | Director | Option Exercise | A | 0.00 | 427 | 0 | 891 | |
| May 10 2019 | IDXX | IDEXX LABORATORIES ... | Claflin Bruce L. | Director | Option Exercise | A | 245.79 | 1,404 | 345,089 | 1,404 | |
| May 10 2019 | IDXX | IDEXX LABORATORIES ... | Claflin Bruce L. | Director | Option Exercise | A | 0.00 | 427 | 0 | 1,958 | |
| May 07 2019 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Sell | S | 250.00 | 2,015 | 503,750 | 15,195 | 17.2 K to 15.2 K (-11.71 %) |
| May 06 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 44.05 | 7,504 | 330,514 | 0 | |
| May 06 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 248.79 | 629 | 156,492 | 47,528 | 48.2 K to 47.5 K (-1.31 %) |
| May 06 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 248.28 | 5,771 | 1,432,819 | 48,157 | 53.9 K to 48.2 K (-10.70 %) |
| May 06 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 247.28 | 225 | 55,638 | 53,928 | 54.2 K to 53.9 K (-0.42 %) |
| May 06 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 245.77 | 375 | 92,165 | 54,153 | 54.5 K to 54.2 K (-0.69 %) |
| May 06 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 244.57 | 300 | 73,372 | 54,528 | 54.8 K to 54.5 K (-0.55 %) |
| May 06 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 242.72 | 204 | 49,514 | 54,828 | 55 K to 54.8 K (-0.37 %) |
| May 06 2019 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 44.05 | 7,504 | 330,514 | 55,032 | 47.5 K to 55 K (+15.79 %) |
| May 06 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Option Exercise | M | 45.84 | 28,000 | 1,283,520 | 83,820 | |
| May 06 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Sell | S | 250.02 | 100 | 25,002 | 1,025,916 | 1 M to 1 M (-0.01 %) |
| May 06 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Sell | S | 249.62 | 13,900 | 3,469,703 | 1,026,016 | 1 M to 1 M (-1.34 %) |
| May 06 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Sell | S | 248.57 | 11,400 | 2,833,693 | 1,039,916 | 1.1 M to 1 M (-1.08 %) |
| May 06 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Sell | S | 247.81 | 2,600 | 644,302 | 1,051,316 | 1.1 M to 1.1 M (-0.25 %) |
| May 06 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Buy | M | 45.84 | 28,000 | 1,283,520 | 1,053,916 | 1 M to 1.1 M (+2.73 %) |
| May 02 2019 | IDXX | IDEXX LABORATORIES ... | Vandebroek Sophie V. | Director | Grant | A | 232.00 | 81 | 18,792 | 9,108 | 9 K to 9.1 K (+0.90 %) |
| May 02 2019 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Grant | A | 232.00 | 26 | 6,032 | 2,767 | 2.7 K to 2.8 K (+0.95 %) |
| May 02 2019 | IDXX | IDEXX LABORATORIES ... | ESSIG STUART | Director | Grant | A | 232.00 | 81 | 18,792 | 649 | 568 to 649 (+14.26 %) |
| Feb 27 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 79.54 | 1,156 | 91,948 | 708 | |
| Feb 27 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 208.06 | 834 | 173,523 | 4,389 | 5.2 K to 4.4 K (-15.97 %) |
| Feb 27 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 212.05 | 472 | 100,089 | 5,223 | 5.7 K to 5.2 K (-8.29 %) |
| Feb 27 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 211.70 | 1,223 | 258,907 | 5,695 | 6.9 K to 5.7 K (-17.68 %) |
| Feb 27 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 79.54 | 1,156 | 91,948 | 6,918 | 5.8 K to 6.9 K (+20.06 %) |
| Feb 27 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Gift | G | 0.00 | 8,000 | 0 | 1,025,884 | 1 M to 1 M (-0.77 %) |
| Feb 22 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Option Exercise | M | 45.84 | 3,322 | 152,280 | 0 | |
| Feb 22 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Sell | S | 211.58 | 736 | 155,723 | 5,732 | 6.5 K to 5.7 K (-11.38 %) |
| Feb 22 2019 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Corporate Vice Pres ... | Buy | M | 4,584.00 | 3,322 | 15,228,048 | 6,468 | 3.1 K to 6.5 K (+105.59 %) |
| Feb 22 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Option Exercise | M | 62.00 | 1,612 | 99,944 | 0 | |
| Feb 22 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Chairman, President ... | Buy | M | 62.00 | 1,612 | 99,944 | 1,033,884 | 1 M to 1 M (+0.16 %) |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 178.26 | 1,714 | 305,538 | 6,293 | |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 141.60 | 2,219 | 314,210 | 5,948 | |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 67.85 | 1 | 68 | 1,474 | |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 67.85 | 4,700 | 318,895 | 7,927 | |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 79.54 | 100 | 7,954 | 1,864 | |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Option Exercise | M | 79.54 | 2,866 | 227,962 | 2,866 | |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 209.18 | 1,714 | 358,533 | 5,762 | 7.5 K to 5.8 K (-22.93 %) |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 178.26 | 1,714 | 305,538 | 7,476 | 5.8 K to 7.5 K (+29.75 %) |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 208.95 | 2,219 | 463,665 | 5,762 | 8 K to 5.8 K (-27.80 %) |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 141.60 | 2,219 | 314,210 | 7,981 | 5.8 K to 8 K (+38.51 %) |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Sell | S | 208.90 | 1 | 209 | 5,762 | 5.8 K to 5.8 K (-0.02 %) |
| Feb 20 2019 | IDXX | IDEXX LABORATORIES ... | Studer Jacqueline | CVP, Gen. Counsel & ... | Buy | M | 67.85 | 1 | 68 | 5,763 | 5.8 K to 5.8 K (+0.02 %) |